Search for: "NOVARTIS PHARMACEUTICALS CORP."
Results 241 - 260
of 367
Sort by Relevance
|
Sort by Date
14 Jul 2010, 6:47 pm
Sun Pharmaceutical Industries, Inc. [read post]
12 Jul 2010, 4:29 pm
Schering Corp., 2010 WL 2669304 (2nd Cir., July 06, 2010), the Court affirmed a District Court order denying the defendant's motion for summary judgment on the outside sales exemption. [read post]
8 Jul 2010, 12:56 pm
American Home Products Corp. [read post]
7 Jul 2010, 11:10 am
There is no genuine dispute over the sales path generally traversed by Novartis pharmaceuticals. [read post]
17 Jun 2010, 6:47 am
In its brief, the DOL argues that the district court in that case committed legal error when it concluded that the pharmaceutical sales representatives employed by Novartis Pharmaceutical Corporation (“NPC”) were exempt from the overtime requirements of the FLSA under the outsides sales and administrative exemptions. [read post]
27 May 2010, 3:40 pm
Ortho Pharmaceutical Corp., 995 F. [read post]
27 May 2010, 3:20 am
ICOS Corp. [read post]
23 May 2010, 7:56 am
Novartis Pharmaceuticals Corp. must pay $250 million in punitive damages for a gender discrimination lawsuit. [read post]
13 May 2010, 4:58 pm
Bayer Corp. et al. [read post]
13 May 2010, 12:27 pm
Novartis Pharmaceuticals Corp., 642 F. [read post]
12 May 2010, 1:29 pm
The asthma inhalation powders addressed in the November 2005 FDA warning are: Serevent Diskus (salmeterol xinafoate inhalation powder), made by GlaxoSmithKline; Advair Diskus (fluticasone propionate & salmeterol inhalation powder), made by GlaxoSmithKline; and, Foradil Aerolizer (formoterol fumarate inhalation powder), made by Novartis Pharmaceuticals Corp. [read post]
6 May 2010, 4:12 pm
Novartis Pharmaceuticals Corp., 564 F. [read post]
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
15 Apr 2010, 4:27 am
(EPLAW) Prevacid (Lansoprazole) – US: Takeda files patent infringement complaint against Zydus following Para IV challenge (Patent Docs) Reyataz (Atazanavir) – US: Bristol-Myer Squibb, Novartis file patent infringement suit against Teva following Para IV challenge (Patent Docs) Treximet (Sumatriptan, Naproxen) – US: POZEN enters into settlement agreement with Teva regarding Para IV patent litigation (SmartBrief) Zerit (Stavudine) – US: Promote Innovation files false… [read post]
8 Apr 2010, 9:48 am
Sandoz Pharmaceuticals Corp., 131 F. [read post]
1 Apr 2010, 1:42 pm
Novartis Pharmaceuticals Corp., 2000 WL 33915848 (E.D. [read post]
22 Mar 2010, 4:13 am
Novartis Pharmaceuticals Corp., 564 F. [read post]
18 Mar 2010, 2:30 am
Baxter Healthcare Corp. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
10 Mar 2010, 5:22 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
